Jordan vs Saint Vincent and the Grenadines: Previously treated cases tested for RR-/MDR-TB
Jordan
100.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2022
Jordan rank
1st
Saint Vincent and the Grenadines rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Jordan
- Saint Vincent and the Grenadines
How they compare
Jordan currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 3 times across 5 shared years of data; in 2012 it was Jordan ahead.
Jordan ranks 1st and Saint Vincent and the Grenadines ranks 1st of 180 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Jordan | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.0% | 33.3% | 15.7% | Jordan |
| 2020s | 18.0% | 50.0% | 32.0% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Jordan or Saint Vincent and the Grenadines?
- Jordan, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Jordan and Saint Vincent and the Grenadines?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Saint Vincent and the Grenadines?
- 5 years are reported by both, from 2012 to 2022.
- How do Jordan and Saint Vincent and the Grenadines rank globally for previously treated cases tested for rr-/mdr-tb?
- Jordan ranks 1st and Saint Vincent and the Grenadines ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.